Developer docs
API playgroundTry for free, no card

Search company profiles

Zynex

Full company profile

uuid00006lc

Namestring
Zynex
Legal namestring
Zynex, Inc.
Websiteurl
zynex.com
Company typeenum
Public
Founded yearint
1996
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersEnglewood, United States
HQ citystring
Englewood
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
electrotherapy medical devices, pain management devices, TENS therapy products, orthopedic bracing supplies, patient monitoring technology
Industry3 codes
1Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
CodeHLAHAMAGPrimaryYes
2Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports)
CodeHLAHAMACPrimaryNo
3Pain Medicine (Interventional/Neuropathic Pain)
CodeHLAKAIAMPrimaryNo
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical Appliance and Supplies Manufacturing339113
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Pain Management Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales
TypeHardware Sales
Description

Zynex generates revenue through the sale of electrotherapy medical devices and supplies, including TENS units, electrode pairs, and related accessories. The company historically shipped products directly to patients based on prescriptions and insurance authorizations.

zynexmed.investorroom.com
2Healthcare Claims Billing
TypeTransaction Fee
Description

The company historically billed insurance providers including government payors (TRICARE, Medicare/Medicaid) and private insurers for medical supplies and devices provided to patients. This revenue stream was subject to fraudulent overbilling allegations resulting in legal action.

denverpost.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Zynex engineers, manufactures, markets, and sells its own design of electrotherapy medical devices, including TENS (Transcutaneous Electrical Nerve Stimulation) units and related accessories for pain management, hot/cold compression therapy systems for inflammation and recovery, and bracing and traction orthopedic supports for joint stabilization and post-injury recovery. Products are prescribed by healthcare providers and shipped to patients, often covered by insurance networks including government programs such as TRICARE and private payors such as Humana.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Zynex is a medical technology company that offers a portfolio of electrotherapy products, including TENS devices and related pain management solutions. The company also provides hot/cold compression therapy and bracing/traction products for orthopedic support and recovery. Zynex's products are designed for pain management, muscle re-education, and functional recovery. The company expanded into patient monitoring through the acquisition of Kestrel Labs. Following bankruptcy and resolution of federal investigations, Zynex was acquired by Altivera Medical and now operates as a private subsidiary.

Product and service4 records
1Electrotherapy (TENS Devices)
CategoryPain Management Medical Devices
Description

Proprietary TENS (Transcutaneous Electrical Nerve Stimulation) devices and related electrotherapy products engineered to relieve pain, stimulate muscle re-education, and support functional recovery, prescribed by healthcare providers for patients with pain management and rehabilitation needs.

2Hot/Cold Compression Therapy
CategoryPain Management Medical Devices
Description

Compression and temperature therapy systems designed to reduce inflammation, relieve discomfort, and promote healing during patient recovery.

3Bracing & Traction
CategoryOrthopedic Medical Devices
Description

Orthopedic support systems designed to stabilize joints, protect healing tissue, and support recovery following injury or surgery.

4Kestrel Labs (Patient Monitoring)
CategoryPatient Monitoring Technology
Description

Patient monitoring products and technology acquired by Zynex through the December 2021 acquisition of Kestrel Labs to expand its medical technology offerings beyond electrotherapy.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-03-27
Description

Altivera Medical acquired Zynex, Inc. in a deal approved by the U.S. Bankruptcy Court for the Southern District of Texas, completing Zynex's Chapter 11 restructuring process. The acquisition resolved pending government investigations and substantially reduced and reorganized Zynex's debts. Zynex is now operating as a private subsidiary of Altivera Medical.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-02-04
Description

Zynex entered into a provider agreement with Humana Inc. effective February 1, 2026, allowing its electrotherapy products to be offered through Humana's health plans. The collaboration aimed to expand patient access to Zynex's pain management devices.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Össur is a global leader in orthopedic bracing, supports, and prosthetics sold through orthopedic specialists and DME distributors. It competes directly with Zynex's bracing & traction products in musculoskeletal and post-injury recovery.

TypeBroad incumbent
Description

Masimo is a global leader in patient monitoring and pulse oximetry technology, overlapping with the patient monitoring portfolio Zynex acquired via Kestrel Labs. As a large incumbent, Masimo competes for hospital and clinical monitoring contracts.

TypeEmerging player
Description

iReliev sells consumer and clinical TENS/EMS units and accessories through direct-to-consumer channels. It competes with Zynex's TENS device business in the home-use pain management segment, though Zynex's prescription-driven model is differentiated.

TypeBroad incumbent
Description

Philips operates a large patient monitoring and connected care business that competes with Kestrel Labs products in clinical settings. Its broader portfolio also includes sleep and respiratory care adjacent to Zynex's rehabilitation positioning.

TypeEmerging player
Description

Neurometrix develops wearable neurostimulation devices (e.g., Quell) for chronic pain, overlapping with Zynex's electrotherapy pain management positioning. Both companies target non-opioid, non-invasive pain relief but Neurometrix focuses on neurostimulation rather than TENS.

TypeDirect peer
Description

BioElectronics manufactures wearable, drug-free electrotherapy and PEMF devices for pain management and post-surgical recovery. It targets overlapping patient segments with Zynex's TENS units and chronic pain use cases.

TypeDirect peer
Description

Breg designs and distributes orthopedic bracing, cold therapy, and pain management products sold through physicians and DME channels. Its product mix directly overlaps Zynex's bracing & traction and hot/cold compression lines for post-surgical and sports medicine recovery.

TypeDirect peer
Description

Enovis owns the Chattanooga and Compex brands, which are direct competitors to Zynex in TENS/EMS electrotherapy, hot/cold therapy, and orthopedic bracing. Both companies serve physical therapy clinics, physicians, and direct-to-patient channels for pain management and rehabilitation.

TypeDirect peer
Description

Performance Health distributes TENS units, hot/cold therapy, and orthopedic braces to physical therapists, chiropractors, and consumers. Its product catalog substantially overlaps Zynex's electrotherapy, hot/cold, and bracing lines.

TypeEmerging player
Description

Hollywog designs and sells WiTouch and similar wireless TENS devices for back pain, directly competing in the consumer/clinical electrotherapy category. It pursues similar DME distribution and prescription-based fulfillment models.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Zynex

Pain Management Medical Deviceszynex.com

Zynex firmographics

Firmographics
Name
Zynex
Legal name
Zynex, Inc.
Website
https://zynex.com
Company type
Public
Founded year
1996
Operating status
Operating
Headcount range
501–1,000 employees
Ownership category
akta.pro rank

Zynex industry classification

Industry
Product category
Pain Management Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)
akta.pro secondary industries
Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports) (HLAHAMAC), Pain Medicine (Interventional/Neuropathic Pain) (HLAKAIAM)

Keywords

  • Electrotherapy medical devices
  • Pain management devices
  • TENS therapy products
  • Orthopedic bracing supplies
  • Patient monitoring technology

Where Zynex is headquartered

Location

Headquarters

HQ city
Englewood
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Zynex business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical Device Sales: Zynex generates revenue through the sale of electrotherapy medical devices and supplies, including TENS units, electrode pairs, and related accessories. The company historically shipped products directly to patients based on prescriptions and insurance authorizations.
  2. Healthcare Claims Billing: The company historically billed insurance providers including government payors (TRICARE, Medicare/Medicaid) and private insurers for medical supplies and devices provided to patients. This revenue stream was subject to fraudulent overbilling allegations resulting in legal action.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels1 record

Zynex product offering

Product offering

Core offering

Zynex engineers, manufactures, markets, and sells its own design of electrotherapy medical devices, including TENS (Transcutaneous Electrical Nerve Stimulation) units and related accessories for pain management, hot/cold compression therapy systems for inflammation and recovery, and bracing and traction orthopedic supports for joint stabilization and post-injury recovery. Products are prescribed by healthcare providers and shipped to patients, often covered by insurance networks including government programs such as TRICARE and private payors such as Humana.

Product overview

Zynex is a medical technology company that offers a portfolio of electrotherapy products, including TENS devices and related pain management solutions. The company also provides hot/cold compression therapy and bracing/traction products for orthopedic support and recovery. Zynex's products are designed for pain management, muscle re-education, and functional recovery. The company expanded into patient monitoring through the acquisition of Kestrel Labs. Following bankruptcy and resolution of federal investigations, Zynex was acquired by Altivera Medical and now operates as a private subsidiary.

Differentiator

Problem solved

Functional benefit

Products and services

  • Electrotherapy (TENS Devices) Proprietary TENS (Transcutaneous Electrical Nerve Stimulation) devices and related electrotherapy products engineered to relieve pain, stimulate muscle re-education, and support functional recovery, prescribed by healthcare providers for patients with pain management and rehabilitation needs.
  • Hot/Cold Compression Therapy Compression and temperature therapy systems designed to reduce inflammation, relieve discomfort, and promote healing during patient recovery.
  • Bracing & Traction Orthopedic support systems designed to stabilize joints, protect healing tissue, and support recovery following injury or surgery.
  • Kestrel Labs (Patient Monitoring) Patient monitoring products and technology acquired by Zynex through the December 2021 acquisition of Kestrel Labs to expand its medical technology offerings beyond electrotherapy.

Companies that use Zynex

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Zynex technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Zynex partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered flagship and core.

  • Altivera Medical Holdings, LLCflagshipStrategic or Co-development Partner · 27 March 2026Altivera Medical acquired Zynex, Inc. in a deal approved by the U.S. Bankruptcy Court for the Southern District of Texas, completing Zynex's Chapter 11 restructuring process. The acquisition resolved pending government investigations and substantially reduced and reorganized Zynex's debts. Zynex is now operating as a private subsidiary of Altivera Medical.
  • Humana Inc.coreChannel Partner/ Reseller/ Distributor · 4 February 2026Zynex entered into a provider agreement with Humana Inc. effective February 1, 2026, allowing its electrotherapy products to be offered through Humana's health plans. The collaboration aimed to expand patient access to Zynex's pain management devices.

Scale indicators9 records

Recent moves8 records

Expansion highlights4 records

Zynex competitors and assessment

Company assessment

Direct peers

  • Össur: Össur is a global leader in orthopedic bracing, supports, and prosthetics sold through orthopedic specialists and DME distributors. It competes directly with Zynex's bracing & traction products in musculoskeletal and post-injury recovery.
  • BioElectronics: BioElectronics manufactures wearable, drug-free electrotherapy and PEMF devices for pain management and post-surgical recovery. It targets overlapping patient segments with Zynex's TENS units and chronic pain use cases.
  • Breg: Breg designs and distributes orthopedic bracing, cold therapy, and pain management products sold through physicians and DME channels. Its product mix directly overlaps Zynex's bracing & traction and hot/cold compression lines for post-surgical and sports medicine recovery.
  • Enovis (DJO): Enovis owns the Chattanooga and Compex brands, which are direct competitors to Zynex in TENS/EMS electrotherapy, hot/cold therapy, and orthopedic bracing. Both companies serve physical therapy clinics, physicians, and direct-to-patient channels for pain management and rehabilitation.
  • Performance Health / Compass Health: Performance Health distributes TENS units, hot/cold therapy, and orthopedic braces to physical therapists, chiropractors, and consumers. Its product catalog substantially overlaps Zynex's electrotherapy, hot/cold, and bracing lines.

Broad incumbents

  • Masimo: Masimo is a global leader in patient monitoring and pulse oximetry technology, overlapping with the patient monitoring portfolio Zynex acquired via Kestrel Labs. As a large incumbent, Masimo competes for hospital and clinical monitoring contracts.
  • Philips (Patient Monitoring): Philips operates a large patient monitoring and connected care business that competes with Kestrel Labs products in clinical settings. Its broader portfolio also includes sleep and respiratory care adjacent to Zynex's rehabilitation positioning.

Emerging players

  • iReliev: iReliev sells consumer and clinical TENS/EMS units and accessories through direct-to-consumer channels. It competes with Zynex's TENS device business in the home-use pain management segment, though Zynex's prescription-driven model is differentiated.
  • Neurometrix: Neurometrix develops wearable neurostimulation devices (e.g., Quell) for chronic pain, overlapping with Zynex's electrotherapy pain management positioning. Both companies target non-opioid, non-invasive pain relief but Neurometrix focuses on neurostimulation rather than TENS.
  • Hollywog: Hollywog designs and sells WiTouch and similar wireless TENS devices for back pain, directly competing in the consumer/clinical electrotherapy category. It pursues similar DME distribution and prescription-based fulfillment models.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

Zynex social profiles

Digital presence

Zynex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Zynex leadership team

Management profile

Number of profiles

Profiles5 records

Zynex subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Zynex funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Zynex M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zynex

What does Zynex do?

Zynex engineers, manufactures, markets, and sells its own design of electrotherapy medical devices, including TENS (Transcutaneous Electrical Nerve Stimulation) units and related accessories for pain management, hot/cold compression therapy systems for inflammation and recovery, and bracing and traction orthopedic supports for joint stabilization and post-injury recovery. Products are prescribed by healthcare providers and shipped to patients, often covered by insurance networks including government programs such as TRICARE and private payors such as Humana.

Is Zynex a public or private company?

Zynex is a public company. It is classified as corporate owned and is currently operating.

When was Zynex founded?

Zynex was founded in 1996. It employs 501 to 1,000 people.

Where is Zynex based?

Zynex is headquartered in Englewood, United States, in the North America region.

How does Zynex make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are healthcare Claims Billing.

Who are Zynex's main competitors?

Direct peers on record are Össur, BioElectronics, Breg, Enovis (DJO) and Performance Health / Compass Health. Broad incumbents are Masimo and Philips (Patient Monitoring). Emerging players are iReliev, Neurometrix and Hollywog.

Does Zynex have an API?

No public API is recorded for Zynex.

What industry is Zynex in?

Zynex's product category is Pain Management Medical Devices. Its primary akta.pro industry code is HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices), with a secondary code of HLAHAMAC, Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Defense WorldCritical Survey: Zynex (NASDAQ:ZYXI) versus Tactile Systems Technology (NASDAQ:TCMD)Tactile Systems Technology and Zynex are compared on revenue, earnings, analyst ratings, and profitability. Tactile Systems Technology has higher revenue ($329.52M vs $108.20M) and earnings, while Zynex trades at a lower P/E ratio. Analysts rate Tactile Systems Technology more favorably with a 74.39% upside.American Banking and Market NewsTactile Systems Technology (NASDAQ:TCMD) vs. Zynex (NASDAQ:ZYXI) Head to Head ContrastTactile Systems Technology and Zynex are compared on valuation, analyst ratings, institutional ownership, and profitability. Tactile Systems Technology beats Zynex on 12 of 14 factors, with higher revenue, earnings, and institutional ownership, and a consensus target price of $38.40 implying 74.39% upside.American Banking and Market NewsAnalyzing Zynex (NASDAQ:ZYXI) and Cytosorbents (NASDAQ:CTSO)Cytosorbents and Zynex are compared on profitability, valuation, risk, and analyst ratings. Cytosorbents beats Zynex on 8 of 14 factors, with a consensus price target of $107.50 implying 2,656% upside. Zynex has higher revenue and earnings but a lower analyst rating.American Banking and Market NewsContrasting Anteris Technologies Global (NASDAQ:AVR) and Zynex (NASDAQ:ZYXI)Anteris Technologies Global and Zynex are compared on profitability, analyst ratings, and valuation. Anteris has a stronger consensus rating and a 96% upside target, while Zynex shows higher revenue and earnings. Anteris is also more volatile with a beta of 1.8.Markets DailyAnteris Technologies Global (NASDAQ:AVR) versus Zynex (NASDAQ:ZYXI) Financial AnalysisZynex and Anteris Technologies Global are compared on valuation, profitability, and analyst ratings. Zynex has higher revenue and earnings, but Anteris trades at a lower P/E and has a stronger consensus rating with an 83.49% upside target.Markets DailyAvita Medical (NASDAQ:RCEL) vs. Zynex (NASDAQ:ZYXI) Critical ComparisonAvita Medical and Zynex are compared on valuation, earnings, and analyst ratings. Avita Medical beats Zynex on 8 of 14 factors, with a consensus price target of $11.40 implying 15.38% upside. Zynex has higher revenue and earnings, but Avita is more affordable and less volatile.Ticker ReportHead to Head Survey: Avita Medical (NASDAQ:RCEL) & Zynex (NASDAQ:ZYXI)Avita Medical and Zynex are compared on valuation, profitability, risk, and analyst ratings. Avita Medical beats Zynex on 8 of 14 factors, with a consensus target price of $11.40 and a 1.79% upside. Zynex has higher revenue and earnings, but Avita is more affordable.Ticker ReportHead to Head Survey: Zynex (NASDAQ:ZYXI) versus Bionik Laboratories (OTCMKTS:BNKL)Bionik Laboratories beats Zynex on 5 of 9 factors, including profitability and analyst ratings. Zynex has higher revenue and earnings but a lower price-to-earnings ratio, while Bionik has higher institutional ownership. Analysts favor Bionik due to higher possible upside.PR NewswirePhysiotherapy Equipment Market worth $8.37 billion by 2031 - Exclusive Report by MarketsandMarkets™MarketsandMarkets projects the physiotherapy equipment market to grow from $6.11 billion in 2026 to $8.37 billion by 2031, a 6.5% CAGR. North America holds the largest share at 30-35% in 2025, and the musculoskeletal & orthopedic segment dominates by application.PR NewswireKuehn Law Encourages Investors of Zynex, Inc. to Contact Law FirmKuehn Law, PLLC announced it is investigating whether officers and directors of Zynex, Inc. (NASDAQ: ZYXI) breached their fiduciary duties to shareholders. The federal securities lawsuit alleges Zynex misled investors by shipping products in excess of need to inflate revenue, and that the company's practice of filing false claims drew scrutiny from insurers including Tricare. The lawsuit claims these practices were reasonably likely to result in adverse consequences such as removal from insurer networks and federal penalties.